Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-386436

Chief Executive Officer sold 8,210 shares at an average $45.61 ($374,498)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ceesay Abraham Chief Executive Officer 2026-09-08 Sale 10b5-1 −7,141 $45.56 $325,308 460,046 D
Ceesay Abraham Chief Executive Officer 2026-09-08 Sale 10b5-1 −1,069 $46.01 $49,190 458,977 D
Open-market sales · 8,210 sh · avg $45.61 · $374,498
Loading xslF345X06/ownership.xml…